Thomas G. Pretlow

A new human prostate carcinoma cell line, 22Rv1

R. Michael Sramkoski, Thomas G. Pretlow, Joseph M. Giaconia et al. · In Vitro Cellular & Developmental Biology - Animal · 1999 · 591 citations

Medicine, Cell Biology, Oncology +6

Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells

Jiann-an Tan, Yousuf Sharief, Katherine G. Hamil et al. · Molecular Endocrinology · 1997 · 359 citations · Full text

Medicine, Molecular Biology, Oncology +17

Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate

Theresa P. Pretlow, Mary Ann O’Riordan, Gregory A. Somich et al. · Carcinogenesis · 1992 · 282 citations

Medicine, Oncology, Pharmacology +12

Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes.

Christopher W. Gregory, Katherine G. Hamil, Desok Kim et al. · PubMed · 1998 · 273 citations

Medicine, Endocrinology, Oncology +9

Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line.

Clifford G. Tepper, David L. Boucher, Philip Ryan et al. · PubMed · 2002 · 264 citations

Medicine, Molecular Biology, Oncology +17